Preprint Review Version 1 This version is not peer-reviewed

Unveiling the Molecular Mechanisms of the Placenta Accreta Spectrum

Version 1 : Received: 18 July 2024 / Approved: 19 July 2024 / Online: 19 July 2024 (11:54:51 CEST)

How to cite: Lizárraga-Verdugo, E.; Beltrán-Ontiveros, S. A.; Gutiérrez-Grijalva, E. P.; Avendaño-Félix, M.; Gutiérrez-Arzapalo, P. Y.; Gutiérrez-Castro, K. P.; Montoya-Moreno, M.; Cuén-Lazcano, D. E.; González-Quintero, P.; Mora-Palazuelos, C. E. Unveiling the Molecular Mechanisms of the Placenta Accreta Spectrum. Preprints 2024, 2024071604. https://doi.org/10.20944/preprints202407.1604.v1 Lizárraga-Verdugo, E.; Beltrán-Ontiveros, S. A.; Gutiérrez-Grijalva, E. P.; Avendaño-Félix, M.; Gutiérrez-Arzapalo, P. Y.; Gutiérrez-Castro, K. P.; Montoya-Moreno, M.; Cuén-Lazcano, D. E.; González-Quintero, P.; Mora-Palazuelos, C. E. Unveiling the Molecular Mechanisms of the Placenta Accreta Spectrum. Preprints 2024, 2024071604. https://doi.org/10.20944/preprints202407.1604.v1

Abstract

Placenta accreta spectrum (PAS) disorders are characterized by abnormal trophoblastic invasion into the myometrium, leading to significant maternal health risks. PAS includes placenta accreta (invasion <50% of the myometrium), increta (invasion >50%), and percreta (invasion through the entire myometrium). The condition is most associated with previous cesarean deliveries, and its incidence increases with the number of cesareans. Other risk factors include advanced maternal age, multiparity, and various uterine surgeries. The increasing global cesarean rates heighten the importance of early PAS diagnosis and management. The study reviewed molecular mechanisms driving PAS, focusing on signaling pathways, genetic expression, biomarkers, and non-coding RNAs involved in trophoblastic invasion. It explored genetic expression and key regulatory processes such as apoptosis, cell proliferation, invasion, and inflammation. The manuscript was compiled from recent scientific literature (2014 – 2024) from the Scopus, PubMed, Google Scholar, and Web of Science databases. Placenta Acreta Spectrum; acreta; increta; percreta; trophoblast invasion; miRNAs, lncRNAs; genetic expression; biomarkers; signaling pathways were the employed keywords to compile relevant literature. The PAS is an important obstetric health problem that challenges maternal health risks associated with abnormal trophoblastic invasion that relies on abnormal placentation, uterine scarring, and impaired decidualization. Identifying new biomarkers like AFP, sFlt-1, β-hCG, PlGF, and PAPP-A aids early detection and management. Understanding genetic expression and non-coding RNAs is crucial for unraveling PAS complexities. Besides, aberrant signaling pathways like Notch, PI3K/Akt, STAT3, and TGF-β offer potential therapeutic targets to modulate trophoblastic invasion. This review underscores the need for interdisciplinary care, early diagnosis, and ongoing research into PAS biomarkers and molecular mechanisms to improve prognosis and quality of life for affected women.

Keywords

placenta accreta spectrum; trophoblast invasion; placenta acreta; placenta increta; placenta percreta

Subject

Public Health and Healthcare, Other

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.